NTLA

Intellia Therapeutics, Inc. $11.87 1M +0.3% 3M -2.0% YTD +28.9% as of 2026-09-14
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.1%
Next 1 week
-0.9%
Next 1 month
-1.2%
Seasonality
Weak window historically
Next 30 days (to Oct 15): -13.3% median, 33% of the last 9 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 36
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.07%/day.
Mean-reversion stats →
1-month breakdown — Market · β 2.36 -1.1% · Seasonal tilt (9y) -0.1%
$42M/day volume 99% volatility +4% 1-year
52-week range · 19% of the way up · -58% from the high
$7.95$28.25

Congressional trades in NTLA Full tracker →

3 members · 8 buys / 8 sells · $58K–$345K disclosed · latest filing Sep 5, 2023.

SELL TC Thomas R Carper · traded Aug 25, 2023 $1K–$15K
BUY TC Thomas R Carper · traded May 22, 2023 $1K–$15K
SELL DB Donald Sternoff Beyer · traded Feb 28, 2022 $15K–$50K
SELL DB Donald Sternoff Beyer · traded Oct 29, 2021 $1K–$15K
SELL DB Donald Sternoff Beyer · traded Sep 20, 2021 $1K–$15K
SELL DB Donald Sternoff Beyer · traded Jul 21, 2021 $1K–$15K
BUY TC Thomas R Carper · traded Nov 20, 2020 $1K–$15K
SELL DB Donald Sternoff Beyer · traded Jan 15, 2021 $1K–$15K

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 51 days) · EPS est. -0.79.

1-day std dev
7.5%
Finished up
52%
Biggest pop
+14.3%
Biggest drop
-22.7%

Standard deviation of the close-to-close move over the last 42 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.